Pliant Therapeutics, Inc.

PLRX·NASDAQ·$1.24Share Price as of 11/2·$77MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/11/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202503/11/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/11/26 8-KCurrent report07/13/26 8-KCurrent report06/11/26 8-KCurrent report05/11/26 8-KCurrent report04/17/26

Prospectuses and Registrations

S-3Shelf registration03/30/26 S-8Registration of securities for employees03/11/26 S-8Registration of securities for employees03/03/25 S-8Registration of securities for employees02/27/24 S-3ASRAutomatic shelf registration03/27/23

Proxies

DEF 14ADefinitive proxy04/22/26 DEFA14AAdditional proxy materials04/22/26 DEF 14ADefinitive proxy04/23/25 DEFA14AAdditional proxy materials04/23/25 PRER14APreliminary proxy (revised)04/11/25

Ownership

Form 3Initial insider ownership10/02/26 Form 4Insider transaction10/02/26 SC 13GBeneficial ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 3Initial insider ownership07/13/26

Other

ARSAnnual report to shareholders04/22/26 EFFECTRequest for effectiveness04/06/26 CORRESPCorrespondence with the SEC04/02/26 UPLOADLetter from the SEC04/02/26 8-A12B8-A12B03/13/25